Perinatal mental health has become a significant focus of interest in recent years, with
investment in new specialist mental health services in some high‐income countries, and …

Since the discovery of chlorpromazine (CPZ) in 1952, first-generation antipsychotics (FGAs)
have revolutionized psychiatric care in terms of facilitating discharge from hospital and …

This report aims to provide methodological guidance to help practitioners select the most
appropriate weighting method based on propensity scores for their analysis out of many …

Nausea and vomiting of pregnancy (NVP) is a common condition that affects as many as
70% of pregnant women. Although no consensus definition is available for hyperemesis …

Decisions about the use of psychotropic medication in pregnancy are an ongoing challenge
for clinicians and women with mental health problems, owing to the uncertainties around …

There are significant differences between men and women in the efficacy and tolerability of
antipsychotic drugs. Here, we provide a comprehensive overview of what is currently known …

These updated guidelines from the British Association for Psychopharmacology replace the
original version published in 2011. They address the scope and targets of pharmacological …

Lithium is an effective treatment in pregnancy and postpartum for the prevention of relapse
in bipolar disorder. However, lithium has also been associated with risks during pregnancy …

Purpose Because preapproval clinical trials typically exclude pregnant women, the evidence
on drug safety during pregnancy required to inform drug labeling must come from …

Background Despite significant teratogenic risks, sodium valproate is still widely prescribed
in many countries to women of childbearing age, as a mood stabiliser in bipolar disorder …